Literature DB >> 29487102

Teriparatide-induced atrial tachycardia.

Jeffrey B Ziffra1, Brian Olshansky2.   

Abstract

We present the case of a patient who presented with worsening chest pain and tachycardia. We were able to monitor her remotely through her pacemaker. She had been started on the injectable medication teriparatide (Forteo) and since then she had an increase in her symptoms. She was found to have intermittent atrial tachycardia with 1:1 conduction and occasional atrioventricular block transiently, coinciding with her injection of teriparatide. This specific-associated arrhythmia has yet to be described. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  arrhythmias; calcium and bone; endocrine system; pacing and electrophysiology

Mesh:

Substances:

Year:  2018        PMID: 29487102      PMCID: PMC5847955          DOI: 10.1136/bcr-2017-223035

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

Review 1.  Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

Authors:  Anthony B Hodsman; Douglas C Bauer; David W Dempster; Larry Dian; David A Hanley; Steven T Harris; David L Kendler; Michael R McClung; Paul D Miller; Wojciech P Olszynski; Eric Orwoll; Chui Kin Yuen
Journal:  Endocr Rev       Date:  2005-03-15       Impact factor: 19.871

2.  Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective.

Authors:  Steven Boonen; Fernando Marin; Dan Mellstrom; Li Xie; Durisala Desaiah; John H Krege; Clifford J Rosen
Journal:  J Am Geriatr Soc       Date:  2006-05       Impact factor: 5.562

Review 3.  Safety of pharmacotherapy of osteoporosis in cardiology patients.

Authors:  Tomasz Zapolski; Andrzej Wysokiński
Journal:  Cardiol J       Date:  2010       Impact factor: 2.737

4.  Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis.

Authors:  Julie Satterwhite; Michael Heathman; Paul D Miller; Fernando Marín; Emmett V Glass; Harald Dobnig
Journal:  Calcif Tissue Int       Date:  2010-10-16       Impact factor: 4.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.